Claes, Christa; Graf von der Schulenburg, Johann-Matthias - In: PharmacoEconomics 21 (2003) 8, pp. 587-600
Background: The introduction of the conjugate vaccine PnC-7 implies that a pneumococcal vaccine is available, for the first time, which also gives children under the age of 2 years reliable protection against invasive pneumococcal infections and offers some protection against non-invasive...